Achilles Kintiroglou Sells 577 Shares of AdvanSix (NYSE:ASIX) Stock

AdvanSix (NYSE:ASIX) SVP Achilles Kintiroglou sold 577 shares of AdvanSix stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $20.00, for a total transaction of $11,540.00. Following the completion of the transaction, the senior vice president owned 30,265 shares of the company’s stock, valued at $605,300. This represents a 1.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

AdvanSix Price Performance

AdvanSix stock opened at $19.67 on Friday. The firm has a market capitalization of $528.02 million, a P/E ratio of 6.93 and a beta of 1.64. AdvanSix has a one year low of $17.97 and a one year high of $33.00. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.35 and a quick ratio of 0.66. The business has a fifty day moving average price of $20.13 and a 200-day moving average price of $21.84.

AdvanSix Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th were paid a $0.16 dividend. The ex-dividend date was Tuesday, August 12th. This represents a $0.64 annualized dividend and a yield of 3.3%. AdvanSix’s dividend payout ratio is currently 22.54%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of AdvanSix in a research report on Saturday, September 27th. Wall Street Zen lowered AdvanSix from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $33.50.

Institutional Trading of AdvanSix

Hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. purchased a new position in shares of AdvanSix during the second quarter worth approximately $29,000. Osaic Holdings Inc. raised its position in AdvanSix by 60.2% in the 2nd quarter. Osaic Holdings Inc. now owns 1,285 shares of the company’s stock worth $31,000 after purchasing an additional 483 shares during the period. GAMMA Investing LLC lifted its stake in AdvanSix by 149.5% in the first quarter. GAMMA Investing LLC now owns 1,966 shares of the company’s stock worth $45,000 after purchasing an additional 1,178 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in AdvanSix by 144.1% during the second quarter. Tower Research Capital LLC TRC now owns 2,385 shares of the company’s stock valued at $57,000 after buying an additional 1,408 shares during the period. Finally, Farther Finance Advisors LLC grew its stake in shares of AdvanSix by 1,195.9% during the second quarter. Farther Finance Advisors LLC now owns 3,123 shares of the company’s stock valued at $74,000 after buying an additional 2,882 shares during the last quarter. Institutional investors own 86.39% of the company’s stock.

About AdvanSix

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.